Testing & Procedures

Research & Clinical Trials

Medicor Cardiology proudly serves Central New Jersey through two state-of-the-art facilities in Bridgewater and Hillsborough. Each office offers full cardiac diagnostic testing, laboratory services, and consultative care — all designed to provide the highest quality of cardiac care close to home.

Our Commitment

Leading Innovation in Cardiac Research

Our ongoing involvement in clinical research reflects our dedication to improving the understanding, prevention, and treatment of cardiovascular disease.

At Medicor, each study is managed by a specialized research team who ensures safety, accuracy, and patient comfort from enrollment to follow-up.

Research Benefits Include:

Clinical Studies

Our Research Experience

Medicor Cardiology has contributed to numerous national and international studies focused on cardiac intervention, arrhythmia management, anticoagulation, and lipid control.

Ongoing & Recently Enrolled Trials

EUCLID — Compared Ticagrelor and Clopidogrel in patients with Peripheral Artery Disease.

ACCELERATE — Assessed CETP inhibition with Evacetrapib in high-risk vascular patients.

REVEAL — Evaluated the lipid-modifying effects of Anacetrapib.

PEGASUS — Studied Ticagrelor’s role in preventing thrombotic events after heart attack.

DAL-OUTCOMES — Investigated Dalcetrapib’s effects on cardiovascular risk.

TRILOGY — Compared Prasugrel and Clopidogrel in acute coronary syndrome.

MAGELLAN — Examined prevention of venous thromboembolism in hospitalized patients.

ROCKET — Compared Rivaroxaban and Warfarin for stroke prevention in atrial fibrillation.

HORIZONS-AMI — Studied outcomes with revascularization and stenting in heart attack patients.

IMPROVE-HF — Registry to enhance the use of evidence-based heart failure therapies.

MEDTRONIC OPTIVOL — Evaluated early action triggered by heart failure device monitoring.

Completed Trials

THEMIS — Evaluating the effect of Ticagrelor in patients with Type II Diabetes and Cardiovascular Disease (enrolling).

CAMELLIA — Assessing BELVIQ treatment in patients with obesity, Type II Diabetes, and cardiovascular risk factors (enrolling).

SIELLO —Pacemaker lead study confirming the safety and reliability of BIOTRONIK Siello S leads (enrolling).

ODYSSEY — Evaluating Alliracumab for lowering LDL (“bad”) cholesterol and raising HDL (“good”) cholesterol (enrolling).

BRIDGE — Examining anticoagulation management during temporary interruption of warfarin therapy (enrolling).

GLORIA-AF — Long-term registry study on oral antithrombotic treatment in patients with Atrial Fibrillation (enrolling).

Innovation in Action

Advancing Cardiac Care for Our Community

Through our continued involvement in cardiovascular research, Medicor Cardiology helps shape the future of patient care in New Jersey and beyond — ensuring our community has access to tomorrow’s treatments, today.

What is a clinical trial?

A clinical trial is a carefully monitored research study designed to evaluate the safety and effectiveness of new medications, devices, or treatment methods before they become widely available.

How does Medicor Cardiology participate in research?

Our physicians and research nurses collaborate with national and international organizations to conduct approved studies in cardiology, ensuring patient safety and data accuracy throughout every phase.

Can any patient participate in a clinical trial?

Each study has specific eligibility criteria. If your cardiologist believes you may qualify, they will discuss available options and what participation involves.

Does participating in a study affect my regular care?

No. Your regular care at Medicor Cardiology continues as usual. Clinical trial participation is voluntary and closely coordinated with your physician to ensure continuity and safety.